Board of Directors
The Board of Directors is responsible for the group's system of corporate governance and is ultimately accountable for the group's activities, strategy, risk management and financial performance.
The Chief Executive Officer is responsible for the management of the business and is assisted by the Corporate Executive Team.
-
Sir Philip Hampton
Non-Executive Chairman
Read more -
Emma Walmsley
Chief Executive Officer of GSK
Read more -
Simon Dingemans
Chief Financial Officer
Read more -
Iain Mackay
Chief Financial Officer Designate
Read more -
Dr Hal Barron
Chief Scientific Officer and President, R&D
Read more -
Manvinder Singh (Vindi) Banga
Senior Independent Non-Executive Director
Read more -
Dr Vivienne Cox
Independent Non-Executive Director
Read more -
Lynn Elsenhans
Independent Non-Executive Director
Read more -
Dr Laurie Glimcher
Independent Non-Executive Director
Read more -
Dr Jesse Goodman
Independent Non-Executive Director
Read more -
Judy Lewent
Independent Non-Executive Director
Read more -
Urs Rohner
Independent Non-Executive Director
Read more
Find out more about the Board
-
Role of the Board
The Board is accountable to shareholders for ensuring that GSK is appropriately managed and achieves the strategic objectives it sets
-
Independence of Non-Executive Directors
Our Board considers all of its Non-Executive Directors to be independent in character and judgement
-
The roles of our Chairman and Chief Executive Officer
Sir Philip Hampton is the Chairman of our Board and Emma Walmsley is our Chief Executive Officer (CEO)
-
Directors' contracts
See our Executive Directors' contracts of service, Non-Executive Directors' letters of appointment and information on document inspection
